The idea that you can "catch" shingles is one of the more common misconceptions I hear from patients who arrive worried they've got it. Often, they've recently been near a child with chickenpox or ...

The global Herpes Zoster Ophthalmicus (HZO) Market is projected to grow from USD 5.1 billion in 2025 to USD 6.8 billion by 2035, representing a compound annual growth rate (CAGR) of 2.9% over the ...

Herpes zoster (HZ) corresponds to the reactivation of varicella zoster virus (VZV). Among adults, the ophthalmic division of the trigeminal nerve is one of the most common sites of involvement.

Shingles of any type is believed to affect around 1 in 3 people in their lifetime and it’s estimated that up to 1 million new cases of shingles will occur in the United States each year. Shingles (or ...

Vaccination reduced the risk of heart attack and stroke as well as the risk of herpes zoster ophthalmicus, New evidence bolsters the case that getting a shingles vaccine not only reduces the risk of ...

In adults aged 50 years or older, the 2-dose recombinant zoster vaccine is linked to reduced risk for HZO, acute myocardial infarction, and stroke. HealthDay News — Two doses of recombinant zoster ...

Against herpes zoster ophthalmicus, the adjusted recombinant zoster vaccine effectiveness was 72.9%. HealthDay News — Two doses of recombinant zoster vaccine (RZV) are associated with a reduced risk ...

"These data suggest that health benefits of RZV immunization may extend beyond the well-described prevention of herpes zoster and postherpetic neuralgia." HealthDay News — Two doses of recombinant ...